Skip to main navigation Skip to search Skip to main content

One year of duodenal-jejunal bypass liner therapy (Endobarrier (R)) leads to perturbations in the metabolic profile of urine, plasma and stool of obese diabetic patients.

  • A Ruban
  • , Z Liu
  • , M Glaysher
  • , H Ashrafian
  • , A Miras
  • , C Prechtl
  • , A Goldstone
  • , M Aldhwayan
  • , N Chhina
  • , W Al-Najim
  • , N Johnson
  • , M Patel
  • , J Li
  • , J Byrne
  • , J Teare

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Original languageEnglish
Title of host publicationOBESITY SURGERY
PublisherSpringer
PagesS10-S10
Volume30
Publication statusPublished (in print/issue) - 1 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this